SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIO, Inc. operates as a holding company, which engages in the design, development, manufacture, and sale of smart electric vehicles. It offers its products under the brands NIO, ONVO, and FIREFLY. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Shanghai, China.

NIO Inc - ADR

NIO Inc

NIO is trending as the community debates the impact of recent delivery updates, with bulls focusing on strong year-over-year growth and the rollout of new models like the ONVO L80, while bears highlight persistent concerns over stock dilution and market manipulation. Investors are closely monitoring price action as they look for a breakout from current levels, though discussions remain divided between those accumulating shares for long-term potential and those frustrated by consistent price suppression.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is facing heightened investor scrutiny ahead of its earnings report, with community sentiment divided between concerns over dilution and cash burn versus long-term optimism driven by the R2 platform rollout and production scaling. Investors are closely monitoring management's commentary on production milestones and capital management strategies, as they weigh near-term volatility against the company's ambitious growth targets.

Roblox Corp. engages in the provision of online gaming services. Its platform consists of Roblox Client, Roblox Studio, and Roblox Cloud. Roblox Client is an application that allows users to explore 3D digital worlds. Roblox Studio is the toolset that allows developers and creators to build, publish, and operate 3D experiences and other content accessed with Roblox Client. Roblox Cloud includes the services and infrastructure that power the human co-experience platforms. The company was founded by Erik Cassel and David B. Baszucki in March 2004 and is headquartered in San Mateo, CA.

Roblox Corporation - Ordinary Shares - Class A

Roblox Corp.

Roblox is facing significant downward pressure following weak engagement and bookings guidance, with market sentiment further soured by ongoing concerns regarding child safety and regulatory scrutiny. While some investors argue that the stock's current valuation is an attractive entry point for long-term growth, others remain skeptical due to persistent net losses and the platform's struggle to balance user safety with expansion.

Akanda Corp. is a cannabis cultivation, manufacturing, and distribution company, which engages in the provision of premium quality and ethically sourced medical cannabis products to patients. The company cultivates and processes natural cannabis at facilities in the Kingdom of Lesotho, Africa and intend to supply medicinal-grade cannabis biomass, cannabis flower, and cannabis concentrates to wholesalers. It also imports and sells medical cannabis-based products. The company was founded on July 16, 2021 and is headquartered in New Romney, the United Kingdom.

Akanda Corp

Akanda Corp is experiencing a massive, sentiment-driven rally fueled by an exceptionally low float and extreme short interest, leading to intense speculation about a potential gamma squeeze. While retail investors are actively sharing parabolic price targets and comparing the volatility to previous short-squeeze phenomena, market participants are also closely watching the company's recent pivot toward telecommunications infrastructure as a potential long-term catalyst.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is capturing community attention as investors debate its long-term potential ahead of the upcoming XRP Vegas conference, with many speculating that a major partnership announcement will serve as a key catalyst. While some holders are expressing frustration over price volatility and questioning the project's transparency, a strong base of long-term supporters remains focused on the network's payroll infrastructure and upcoming ecosystem integrations as primary drivers for future growth.

Dogelon Mars

Dogelon Mars continues to trend due to persistent community efforts to drive social engagement and high-frequency trading chatter despite significant historical volatility. Investors are actively discussing the potential for long-term growth driven by speculative hype, meme culture, and hopes for major exchange listings.

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Senseonics Holdings Inc

Senseonics is facing significant downward pressure following an $80 million stock and warrant offering, fueling intense community debate over dilution and leadership's capital management. Investors are actively scrutinizing the company's reliance on secondary offerings and potential reverse split risks, while many express deep frustration with management's performance despite the underlying technology's potential.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is experiencing heightened volatility and selling pressure as investors rotate capital into other tech leaders, despite strong long-term projections for AI-driven data center demand. The community is actively debating whether this pullback represents a temporary consolidation and a buying opportunity or a structural shift driven by concerns over hyperscaler competition and high valuation expectations.

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of immunotherapies to treat cancer and autoimmune diseases. Its products include CUE-400 series (autoimmune diseases), CUE-500 series (targeted cell depletion), and CUE-100 series (Oncology). The company was founded by Ronald D. Seidel III, Steven Almo, and Rodolfo Chaparro on December 31, 2014 and is headquartered in Boston, MA.

Cue Biopharma Inc

Cue Biopharma is currently experiencing significant market volatility driven by a mix of positive development milestones and investor apprehension surrounding a potential reverse stock split. The community is actively debating the company's recent preclinical success and partnership payments versus long-term concerns regarding cash runway, leadership transitions, and dilution.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Dallas, TX.

United States Antimony Corp.

United States Antimony Corp. is trending as investors monitor supply chain tensions following China's critical mineral export controls and the company's role as a domestic producer for defense-related industries. The community is actively debating the stock's volatility and its potential as a strategic play, with heavy discussion surrounding the upcoming earnings report and the impact of institutional accumulation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

LENSAR, Inc. (NASDAQ:LNSR) Short Interest Update

LENSAR, Inc. (NASDAQ:LNSR - Get Free Report) was the target of a large growth in short interest in March. As of March 31st, there was short interest totaling 1,016,420 shares, a growth of 42.2% from the March 15th total of 714,594 shares. Approximately 24.7% of the company's stock are short sold...

LENSAR (NASDAQ:LNSR) Upgraded at Lake Street Capital

Lake Street Capital raised LENSAR from a "hold" rating to a "buy" rating and set a $10.00 price objective for the company in a research note on Wednesday...

LENSAR Q4 Earnings Call Highlights

LENSAR (NASDAQ:LNSR) executives used the company's fourth-quarter and full-year 2025 earnings call to outline how the cataract-laser maker plans to reaccelerate growth as a standalone company...

LENSAR (NASDAQ:LNSR) Releases Earnings Results, Misses Expectations By $0.02 EPS

LENSAR (NASDAQ:LNSR - Get Free Report) announced its quarterly earnings data on Tuesday. The company reported ($0.12) EPS for the quarter, missing analysts' consensus estimates of ($0.10) by ($0.02). The firm had revenue of $16.03 million for the quarter, compared to analyst estimates of $20.30...

LENSAR Stock Plunges Alcon Scraps Merger After Prolonged Regulatory Review

Alcon cancels $356 million LENSAR merger due to regulatory delays and FTC opposition, adding pressure on shares.read more...

<ul class="summary-bullets"><li>Lensar said in a statement that it is disappointed with the outcome and the Federal Trade Commission's intent to challenge the deal.</li><li>Alcon agreed to acquire LENSAR in March 2025 for a total potential consideration of up to $16.75 per share.</li><li>Lensar, despite the termination, will retain the $10.0 million deposit contemplated by the merger agreement, it said.</li></ul>&nbsp;Shares of LENSAR, Inc. (NSR) slumped 24% after hours on Monday after the company terminated its merger agreement with eye care company Alcon Research, LLC (ALC).The commercial-stage medical device company Lensar said on Monday that the company decided to terminate the deal after the two companies concluded that it is in the best interest of both. Lensar further added that the deal is unlikely to receive necessary regulatory approvals in the U.S. by April 23 or even by an extended deadline of July 23.Lensar said in a statement that it is disappointed with the outcome and the Federal Trade Commission's intent to challenge the deal.<h2 class="st-heading-2">The Deal That Fell Through</h2>Alcon agreed to acquire LENSAR in March 2025 for a total potential consideration of up to $16.75 per share. This included an upfront payment of $14 per share in cash and an additional non-tradeable contingent value right offering up to $2.75 per share in cash. Alcon then said that the transaction is anticipated to close in mid-to-late 2025.However, last month Lensar said that it now expects the transaction to close only by the first half of 2026 as the two companies continue to cater to the FTC’s demand for additional information pertaining to the acquisition.“...the delay and associated costs of this extended regulatory review, which began nearly a year ago, has rendered the transaction unattractive to pursue further in light of the Federal Trade Commission’s opposition,” said Alcon CEO David J. Endicott. Lensar, however, will retain the $10.0 million deposit contemplated by the merger agreement, it said.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around LNSR stock stayed within the ‘bullish’ territory while sentiment around ALC remained ‘neutral’.<a href="https://stocktwits.com/symbol/LNSR">LNSR stock</a> has dropped 34% over the past 12 months while <a href="https://stocktwits.com/symbol/ALC">ALC shares</a> fell 13%.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/sarepta-shares-rise-as-company-begins-enrollment-in-gene-therapy-safety-enhancement-study/cZ3PezERIQd">Sarepta Shares Rise As Company Begins Enrollment In Gene Therapy Safety Enhancement Study</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In the wake of OWL's redemption restrictions, Senator Elizabeth Warren called for tighter oversight of private credit.

Lensar Stock Slumps After Hours On Ending Merger Deal With Alcon Over FTC Pushback

Lensar said that its deal with Alcon is unlikely to receive necessary regulatory approvals in the U.S. by April 23 or even by July 23. 

Equity

Lensar said that its deal with Alcon is unlikely to receive necessary regulatory approvals in the U.S. by April 23 or even by July 23. 


Alcon Ends Merger Agreement With LENSAR After FTC Opposition

(RTTNews) - Alcon Inc. (ALC) announced on Monday that it has agreed with LENSAR, Inc. (LNSR) to terminate their previously announced merger agreement...

Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that it has entered into an agreement with LENSAR, Inc. (NASDAQ: LNSR) to terminate...

LENSAR (NASDAQ:LNSR) Stock Price Down 0.9% - Here's Why

LENSAR (NASDAQ:LNSR) Stock Price Down 0.9% - Should You Sell...

LENSAR (LNSR) Projected to Post Earnings on Thursday

LENSAR (NASDAQ:LNSR) will be releasing its Q4 2025 earnings before the market opens on Thursday, February 26. (View Earnings Report at...

LENSAR, Inc. engages in the development of femtosecond laser technology for refractive cataract surgery. Its product offers automation and customization options for astigmatism treatment planning and other steps of the refractive cataract surgery procedure. The company was founded by Scott Addyman, Randy W. Frey, and Ronald R. Krueger in 2004 and is headquartered in Orlando, FL.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	$0.19	--	--	N/A
Q4 '25	-$0.07	-$0.12	-80.72%	MISSED
Q3 '25	--	-$0.31	--	N/A
Q2 '25	-$0.02	-$0.15	-673.20%	MISSED
Q1 '25	-$0.15	-$2.32	-1411.40%	MISSED

LNSR
LENSAR Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest LNSR News

LNSRLENSAR Inc